Position in PCRX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$4,211,420
+$459,820 QoQ
Shares Held
166,000
0.0% QoQ
Ownership
0.416%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#43
of 251 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $5,275,089 across 2 Drug Manufacturers - Specialty & Generic names. PCRX ranks #1 (79.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
This page
|
166,000 | $4,211,420 | |
| 2 | ZTS |
Zoetis Inc.
|
14,802 | $1,063,669 |
All Filings in PCRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,211,420 | 166,000 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,751,600 | 166,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,037,280 | 156,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,942,810 | 153,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,250,400 | 136,000 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $3,528,700 | 142,000 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,390,796 | 126,900 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,806,000 | 120,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,958,851 | 138,373 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||